Dow University of Health Sciences feels pride to share a news that three Alumini of Dow College of Biotechnology, Anusha Amanullah (2020), Ayesha Aslam (2021) and Iffat Waqar (2022) are very instrumental in undertaking a study related to the designing and bioinformatic assesment of a unique mRNA vaccine construct that could potentially be effective against multiple variants of the SARS-CoV-2 under the supervision of Principal and Vice Principal of Dow College of Biotechnology. Their findings are published in Journal Polymers (IF 4.96). Currently all three of alumini are enrolled in DUHS MPhil (Biotechnology) program, reflecting the confidence of our alumini on the University and College Education System and Quality. The sustainability of the academic excellence could also be witnessed that this is Anusha’s 5th, Ayesha’s 2nd and Iffat 1st International Publication on research conducted under the supervision of Dow College of Biotechnology faculty.